You are here: Home » PTI Stories » National » News
Business Standard

Sun Pharma shares gain 4%; m-cap rises by Rs 2,384 cr

Press Trust of India  |  New Delhi 

Shares of Industries today gained nearly 4 per cent after the company received establishment inspection report (EIR) from the US regulator for its facility in

The stock went up by 3.74 per cent to Rs 560.75 on BSE.

On NSE, shares of the company rose by 3.79 per cent to Rs 560.95.

Led by the rally in the stock, the company's market valuation climbed Rs 2,384.55 crore to Rs 1,31,911.60 crore during the morning trade.

The company has received from the Food and Drug Administration (USFDA) for the inspection conducted at the facility during the period February 12-23, 2018, said in a filing to BSE yesterday.

"The agency concluded that the inspection is now closed and the issues contained in the warning letter issued in December 2015 have been addressed," it added.

Commenting on the development, MD Dilip Shanghvi said, "This is an important development for We remain committed to following the highest levels of quality and 24x7 cGMP compliance at all our globally.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, June 13 2018. 12:05 IST